These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 17927590

  • 1. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance.
    Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, André S, Brinck U, Alken P, Gabius HJ.
    Histopathology; 2007 Nov; 51(5):681-90. PubMed ID: 17927590
    [Abstract] [Full Text] [Related]

  • 2. Decreased galectin-8 is a strong marker for recurrence in urothelial carcinoma of the bladder.
    Kramer MW, Waalkes S, Serth J, Hennenlotter J, Tezval H, Stenzl A, Kuczyk MA, Merseburger AS.
    Urol Int; 2011 Nov; 87(2):143-50. PubMed ID: 21757871
    [Abstract] [Full Text] [Related]

  • 3. Transient receptor potential vanilloid type 2 (TRPV2) expression in normal urothelium and in urothelial carcinoma of human bladder: correlation with the pathologic stage.
    Caprodossi S, Lucciarini R, Amantini C, Nabissi M, Canesin G, Ballarini P, Di Spilimbergo A, Cardarelli MA, Servi L, Mammana G, Santoni G.
    Eur Urol; 2008 Sep; 54(3):612-20. PubMed ID: 17977643
    [Abstract] [Full Text] [Related]

  • 4. Varied expression and localization of multiple galectins in different cancer cell lines.
    Satelli A, Rao PS, Gupta PK, Lockman PR, Srivenugopal KS, Rao US.
    Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
    [Abstract] [Full Text] [Related]

  • 5. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
    Matsui Y, Ueda S, Watanabe J, Kuwabara I, Ogawa O, Nishiyama H.
    Cancer Res; 2007 Feb 01; 67(3):1212-20. PubMed ID: 17283157
    [Abstract] [Full Text] [Related]

  • 6. The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II.
    Szöke T, Kayser K, Trojan I, Kayser G, Furak J, Tiszlavicz L, Baumhäkel JD, Gabius HJ.
    Eur J Cardiothorac Surg; 2007 May 01; 31(5):783-7. PubMed ID: 17369045
    [Abstract] [Full Text] [Related]

  • 7. Galectin fingerprinting by immuno- and lectin histochemistry in cutaneous lymphoma.
    Wollina U, Graefe T, Feldrappe S, André S, Wasano K, Kaltner H, Zick Y, Gabius HJ.
    J Cancer Res Clin Oncol; 2002 Feb 01; 128(2):103-10. PubMed ID: 11862481
    [Abstract] [Full Text] [Related]

  • 8. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
    Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, André S, Toubeau G, Gabius HJ, Leroy X.
    Histopathology; 2008 Mar 01; 52(4):483-93. PubMed ID: 18315601
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of CDC91L1 (PIG-U) in bladder urothelial cell carcinoma: correlation with clinical variables and prognostic significance.
    Shen YJ, Ye DW, Yao XD, Trink B, Zhou XY, Zhang SL, Dai B, Zhang HL, Zhu Y, Guo Z, Wu G, Nagpal J.
    BJU Int; 2008 Jan 01; 101(1):113-9. PubMed ID: 17941920
    [Abstract] [Full Text] [Related]

  • 10. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I, Zaravinos A, Karyotis I, Delakas D, Spandidos DA.
    J Urol; 2009 May 01; 181(5):2312-9. PubMed ID: 19303097
    [Abstract] [Full Text] [Related]

  • 11. Galectin-9 as a regulator of cellular adhesion in human oral squamous cell carcinoma cell lines.
    Kasamatsu A, Uzawa K, Nakashima D, Koike H, Shiiba M, Bukawa H, Yokoe H, Tanzawa H.
    Int J Mol Med; 2005 Aug 01; 16(2):269-73. PubMed ID: 16012760
    [Abstract] [Full Text] [Related]

  • 12. Unique sequence and expression profiles of rat galectins-5 and -9 as a result of species-specific gene divergence.
    Lensch M, Lohr M, Russwurm R, Vidal M, Kaltner H, André S, Gabius HJ.
    Int J Biochem Cell Biol; 2006 Aug 01; 38(10):1741-58. PubMed ID: 16740401
    [Abstract] [Full Text] [Related]

  • 13. Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer.
    Kramer MW, Kuczyk MA, Hennenlotter J, Serth J, Schilling D, Stenzl A, Merseburger AS.
    Oncol Rep; 2008 Dec 01; 20(6):1403-8. PubMed ID: 19020721
    [Abstract] [Full Text] [Related]

  • 14. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer.
    Moiseeva EV, Rapoport EM, Bovin NV, Miroshnikov AI, Chaadaeva AV, Krasilshschikova MS, Bojenko VK, Bijleveld C, van Dijk JE, Den Otter W.
    Breast Cancer Res Treat; 2005 Jun 01; 91(3):227-41. PubMed ID: 15952056
    [Abstract] [Full Text] [Related]

  • 15. Galectin-8 up-regulation during hypopharyngeal and laryngeal tumor progression and comparison with galectin-1, -3 and -7.
    Cludts S, Decaestecker C, Mahillon V, Chevalier D, Kaltner H, André S, Remmelink M, Leroy X, Gabius HJ, Saussez S.
    Anticancer Res; 2009 Dec 01; 29(12):4933-40. PubMed ID: 20044599
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
    Alves PM, Godoy GP, Gomes DQ, Medeiros AM, de Souza LB, da Silveira EJ, Vasconcelos MG, Queiroz LM.
    Pathol Res Pract; 2011 Apr 15; 207(4):236-40. PubMed ID: 21397408
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uroplakin gene expression in normal human tissues and locally advanced bladder cancer.
    Olsburgh J, Harnden P, Weeks R, Smith B, Joyce A, Hall G, Poulsom R, Selby P, Southgate J.
    J Pathol; 2003 Jan 15; 199(1):41-9. PubMed ID: 12474225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.